Involvement of the CD95 (APO-1/fas) receptor and ligand in liver damage

Journal of Experimental Medicine

Volumn 182, Issue 5, 1995, Pages 1223-1230

  Galle, Peter R ^a   Hofmann, Walter J ^b   Walczak, Henning ^c   Schaller, Heinz ^d   Otto, Gerd ^a   Stremmel, Wolfgang ^a   Krammer, Peter H ^c   Runkel, Laura ^d,e  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Institute of Pathology   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; MESSENGER RNA;

ALCOHOL LIVER CIRRHOSIS; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN SITU HYBRIDIZATION; KILLER CELL; LIGAND BINDING; LIVER CELL; LIVER FAILURE; LIVER INJURY; PRIORITY JOURNAL; RECEPTOR BINDING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CELLS, CULTURED; COMPARATIVE STUDY; HEPATITIS, VIRAL, HUMAN; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER FAILURE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0028783367     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.5.1223     Document Type: Article

References (47)

1. Bursch, W., F. Oberhammer, and R. Schulte-Hermann. 1992. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13:245-251.
2. Evans, V.G. 1993. Multiple pathways to apoptosis. Cell Biol. Int. 17:461-475.
3. Vaux, D.L., G. Haecker, and A. Strasser. 1994. An evolutionary perspective on apoptosis. Cell. 76:777-779.
4. Schwartz, L.W., and B.A. Osborne. 1993. Programmed cell death, apoptosis and killer genes. Immunol. Today. 12:582-590.
5. Krammer, P.H., I. Behrmann, P. Daniel, J. Dhein, and K.M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6:279-289.
6. Pickup, D.J., B.S. Ink, W. Hu, C.A. Ray, and W. Kinoklik. 1986. Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. USA. 83: 7698-7702.
7. White, E. P. Sabbatini, M. Debbas, W.S.M. Wold, D.I. Kusher, and L.R. Gooding. 1992. The 19kD adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by TNF. Mol. Cell Biol. 12:2570-2580.
8. Roberts, J.M., J.W. Searle, and W.G. Cooksley. 1993. Histological patterns of prolonged hepatitis C infection. Gastroenterology. 26:37-41.
9. Apasov, S., F. Redegeld, and M. Sitkovsky. 1993. Cell-mediated cytotoxicity; contact and secreted factors. Cun. Opin. Immunol. 5:404-410.
10. Lowin, B., M. Hahne, C. Mattmann, andj. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature (Lond.). 370:650-652.
11. Kagi, D., B. Ledermann, K. Biirki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkemagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Land.). 369:31-37.
12. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
13. Heusel, J.W., R.L. Wesselschmidt, S. Stresta, J.H. Russel, and T.J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogenic target cells. Cell. 76:977-987.
14. Smith, C.A., T. Farrah, and R.G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell. 76:959-962.
15. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245:301-305.
16. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to cell surface antigen codownregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
17. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.I. Mizuchima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:2333-2343.
18. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth, et al. Purification and molecular cloning of the APO-1 surface antigen, a member of the TNF/NGF receptor superfamily. J. Biol. Chem. 267:10709-10715.
19. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873-879.
20. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
21. Lynch, D.H., M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough, M. Gibson, T. Davis Smith, C.A. Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity. 1:131-136.
22. 2+-independent T cell-mediated cytotoxicityj. Exp. Med. 177:195-200.
23. Gilette-Ferguson, I., and C.L. Sidman. 1994. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice. Eur.J. Immunol. 24:1181-1185.
24. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:4930-4934.
25. Ju, S.T., H. Cui, D.J. Pauka, R. Ettinger, and A. MarshakRothstein. 1994. Participation of target Fas protein in apoptosis pathway induced by CD4+ Thl and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 91:4185-4189.
26. Stalder, T., S. Hahn, and P. Erb. 1994. Fas antigen is the major target molecule for CD4+ T-cell mediated cytotoxicity. Immunology. 152:1127-1133.
27. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur.J. Immunol. 24:923-927.
28. Leithauser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Briiderlein, C. Henne, A. Schmidt, K.M. Debatin, P.H. Krammer, and P. Moller. 1993. Constitutive and induced expression of APO-1, a new member of the NGF/TNF receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69: 415-429.
29. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effects of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
30. Benedetti, A.A., M. Jezaquel, and F. Orlandi. 1988. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J. Hepatol. 7:319-324.
31. Chisari, F.V. 1992. Hepatitis B virus biology and pathogenesis. Mol. Genet. Med. 2:67-104.
32. Galle, P.R., L. Theilmann, R. Raedsch, G. Otto, and A. Stiehl. 1990. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology. 12:486-491.
33. Galle, P.R., J. Hagelstein, B. Kommerell, M. Volkmann, P. Schranz, and H. Zentgraf. 1994. In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology. 106:664-673.
34. Freshnez, R.I. 1987. Culture of Animal Cells: A Manual of Basic Technique. Alan R. Liss, Inc., New York. 245-246.
35. Dhein, J., P.T. Daniel, B.C. Trauth, A. Oehm, P. Moller, and P.H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149:3166-3173.
36. O’Grady, J.G., S.W. Schalm, and R. Williams. 1993. Acute liver failure: redefining the syndromes. Lancet. 342:273-275.
37. Sanchez, V., M. Lucas, A. Sanz, and R. Gobema. 1992. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes. Biosci. Rep. 12:199-206.
38. Bosch, F.X., N. Udvarhelyi, E. Venter, C. Herold-Mende, A. Schumann, H. Maier, H. Weidauer, and A.I. Born. 1993. Expression of the histone H3 gene in benign, semi-malignant and malignant lesions of the head and neck: a reliable proliferation marker. Eur.J. Cancer. 29A:1454-1461.
39. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567-1574
40. Galle, P.R., H.-J. Schlicht, C. Kuhn, and H. Schaller. 1989. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell. Hepatology. 10:459-465.
41. Ni, R., Y. Tonita, K. Matsuda, A. Ichihara, K. Ishimura, J. Ogasawara, and S. Nagata. 1994. Fas mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res. 215:332-337.
42. Anel, A., M. Buferne, C. Boyer, A.-M. Schmitt-Verhulst, and P. Golstein. 1994. T cell receptor induced Fas ligand expression in cytotoxic T-lymphocyte clones is blocked by protein tyrosin kinase inhibitors and cyclosporin A. Eur.J. Immunol. 24:2469-2476.
43. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APOl/(Fas/CD95). Nature (Lond.). 373:438-441.
44. Ramsdell, F., M.S. Seaman, R.E. Miller, T.W. Tough, M.R. Alderson, and D.H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928-933.
45. Takahashi, T., M. Tanaka, C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
46. Mita, E., N. Hayashi, S. Iio, T. Takehara, T. Hijioka, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Bio phys. Res. Commun. 204:468-474.
47. Nayersina, R., P. Fowler, S. Guilhot, G. Missale, A. Cernay, H.J. Schlicht, A. Vitiello, R. Chesnut, J.L. Person, A.G. Redeker, et al. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.